0001127602-14-020443.txt : 20140624
0001127602-14-020443.hdr.sgml : 20140624
20140610162508
ACCESSION NUMBER: 0001127602-14-020443
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140609
FILED AS OF DATE: 20140610
DATE AS OF CHANGE: 20140610
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS
CENTRAL INDEX KEY: 0000920148
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 133757370
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
BUSINESS PHONE: 3362291127
MAIL ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19940314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boyle James T. Jr.
CENTRAL INDEX KEY: 0001454748
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11353
FILM NUMBER: 14902364
MAIL ADDRESS:
STREET 1: 531 SOUTH SPRING STREET
CITY: BURLINGTON
STATE: NC
ZIP: 27215
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-06-09
0000920148
LABORATORY CORP OF AMERICA HOLDINGS
LH
0001454748
Boyle James T. Jr.
531 SOUTH SPRING STREET
BURLINGTON
NC
27215
1
EVP, Chief Operating Officer
Common Stock
2014-06-09
4
M
0
9800
84.86
A
35621
D
Common Stock
2014-06-09
4
M
0
28800
84.86
A
64421
D
Common Stock
2014-06-09
4
S
0
38600
103.00
D
25821
D
Non-qualified Stock Options
84.86
2014-06-09
4
M
0
9800
0
D
2013-05-24
2022-05-23
Common Stock
9800
48100
D
Non-qualified Stock Options
84.86
2014-06-09
4
M
0
28800
0
D
2013-05-24
2022-05-23
Common Stock
28800
19300
D
The price of $103.00 per share represents a weighted average of sales prices ranging from $102.81 to $103.21 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan.
The option vests in three equal annual installments beginning on the date reflected in this column.
/s/ F. Samuel Eberts III, attorney-in-fact for James T. Boyle
2014-06-10